Search Results | Showing 21 - 30 of 238 results for "Pharmaceutical" |
| | | Uniseed has joined forces with major Australian universities, doubling the number of research partners in the fund. Monash University has joined Uniseed as its full partner, along with the University of Newcastle, University of Technology Sydney, Western ... |
| | | | ... handhold their own investors on the private capital side is critical." The firm intends to market an emerging company pharmaceutical in the coming weeks - the first IPO under the Alpine Capital banner. |
| | | | ... boomers. "They have a few stocks that don't appear in the general baby boomer cohort," it said. "Led by Neuren Pharmaceutical which has seen its price skyrocket in 2023 after announcing FDA approval of its drug which treats Rett syndrome." The other ... |
| | | | These are just some of the recommendations from Grattan Institute ahead of the federal budget, which also include counting more of the family home in the aged pension assets and residential aged care means tests. With Australia on course for 25 straight ... |
| | | | Women-led MySuper products have outperformed on average by a consistent 0.3% per annum over three, five and 10 years, new analysis shows. Rainmaker Information looked at the performance of 18 women-led MySuper products, being those with women in senior ... |
| | | | ... an emerging market, rather than in a developed country," he explained. "For example, we have an amazing Indian pharmaceutical company that has great long-term growth prospects that's providing pharmaceuticals to the Indian population. It's never ... |
| | | | Carlyle has appointed industry veteran Geoff Hutchinson as managing director and head of private equity in Australia and New Zealand. Hutchinson, who is based in Sydney, will build Carlyle's presence in Australasia and have responsibility for leading ... |
| | | | From today, investors can access the AussieEconomy portfolio, an investment basket offering long-term exposure to high performing ASX-listed companies. The 35 stocks that make up the portfolio are from a variety of industries including commodities ... |
| | | | Andrew and Nicola Forrest's Tattarang has backed new biotech venture capital group Tenmile to the tune of $250 million. The company will focus on supporting founders and companies building new, impactful health techbology and biotech solutions. Already ... |
| | | | ... at equity investment focus on companies that have pricing power and can maintain their return. "Healthcare and pharmaceutical stocks have been a "port in the storm, financials have been a little more mixed, and their outlook remains that way," he said. ... |
|